Dilazep
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
3-(4-{3-[(3,4,5-trimethoxyphenyl)carbonyloxy]propyl}-1,4-diazepan-1-yl)propyl 3,4,5-trimethoxybenzoate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | ? |
Identifiers | |
ATC code | C01DX10 |
PubChem | CID 3074 |
ChemSpider | 2965 |
UNII | F8KLC2BD5Z |
KEGG | D07843 |
ChEMBL | CHEMBL126075 |
Chemical data | |
Formula | C31H44N2O10 |
Mol. mass | 604.69 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Dilazep is a vasodilator that acts as an adenosine reuptake inhibitor.[1]
References
- ↑ Hiroshi Deguchi, Hiroyuki Takeya, Hideo Wada, Esteban C. Gabazza, Nobuyuki Hayashi, Hajime Urano, and Koji Suzuki (September 15, 1997). "Dilazep, an Antiplatelet Agent, Inhibits Tissue Factor Expression in Endothelial Cells and Monocytes". Blood 90: 2345–2356.
|
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.